Gabriella Marucci Selected Research

Gabriella Marucci Research Topics

Disease

6	Neoplasms (Cancer) 06/2022 - 11/2010
3	Asthma (Bronchial Asthma) 06/2022 - 03/2010
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2014
3	Neuroinflammatory Diseases 01/2022 - 01/2020
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 03/2003
3	Parkinson Disease (Parkinson's Disease) 01/2022 - 12/2008
3	Pain (Aches) 01/2020 - 07/2013
3	Inflammation (Inflammations) 04/2019 - 01/2015
2	Gastrointestinal Diseases (Functional Gastrointestinal Disorders) 06/2022 - 05/2018
2	Neurodegenerative Diseases (Neurodegenerative Disease) 04/2022 - 01/2022
2	Hypersensitivity (Allergy) 01/2020 - 03/2010
2	Neuralgia (Stump Neuralgia) 01/2019 - 07/2013
2	Chronic Pain 01/2017 - 07/2013
1	Atherosclerosis 06/2022
1	Type 2 Diabetes Mellitus (MODY) 06/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Multiple Sclerosis 01/2022
1	Dementia (Dementias) 01/2021
1	Breast Neoplasms (Breast Cancer) 11/2020
1	Carcinogenesis 11/2020
1	Colitis 01/2020
1	Chronic Cough 12/2019
1	Neuroblastoma 01/2019
1	Brain Ischemia (Cerebral Ischemia) 01/2019
1	Ischemia 01/2019
1	Stroke (Strokes) 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 07/2018
1	Hepatocellular Carcinoma (Hepatoma) 07/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2016
1	Endocrine System Diseases (Endocrine Diseases) 01/2015
1	Cancer Pain 01/2015
1	Adenocarcinoma 01/2014
1	Migraine Disorders (Migraine) 07/2013
1	Astrocytoma (Pilocytic Astrocytoma) 07/2011
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 12/2010
1	Lower Urinary Tract Symptoms 12/2010
1	Rheumatoid Arthritis 11/2010
1	Dry Eye Syndromes (Dry Eye Syndrome) 11/2010
1	Pathologic Processes 11/2010
1	Focal Cortical Dysplasia 09/2009
1	Epilepsy (Aura) 09/2009

Drug/Important Bio-Agent (IBA)

7	Purinergic P1 Receptors (Adenosine Receptor)IBA 06/2022 - 01/2016
5	Adenosine (Adenocard)FDA LinkGeneric 06/2022 - 09/2009
3	LigandsIBA 01/2022 - 07/2013
3	Purinergic P1 Receptor AntagonistsIBA 01/2022 - 05/2018
3	CytokinesIBA 02/2021 - 01/2020
2	Protein Isoforms (Isoforms)IBA 09/2020 - 03/2010
2	AntioxidantsIBA 01/2020 - 01/2019
2	Purinergic P2X3 ReceptorsIBA 04/2019 - 01/2017
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 07/2011 - 03/2010
1	NucleosidesIBA 04/2022
1	Cytostatic AgentsIBA 01/2022
1	N(6)- (3- iodobenzyl)- 5'- N- methylcarboxamidoadenosineIBA 01/2022
1	istradefyllineIBA 01/2022
1	InterferonsIBA 02/2021
1	2'-deoxyadenosineIBA 02/2021
1	Adenine FDA LinkGeneric 02/2021
1	InterleukinsIBA 02/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 02/2021
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2021
1	Tetrahydrofolate Dehydrogenase (Dihydrofolate Reductase)IBA 11/2020
1	Caspase 3 (Caspase-3)IBA 11/2020
1	acetylshikoninIBA 11/2020
1	human ERBB2 proteinIBA 11/2020
1	NaphthoquinonesIBA 11/2020
1	hydroxide ionIBA 09/2020
1	IsoenzymesIBA 09/2020
1	Neuroprotective AgentsIBA 01/2020
1	2,4-dinitrobenzeneIBA 01/2020
1	Adenosine A3 ReceptorIBA 01/2020
1	Sulfonic AcidsIBA 01/2020
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020
1	2,4-dinitrofluorobenzene sulfonic acidIBA 01/2020
1	BLU-5937IBA 12/2019
1	GefapixantIBA 12/2019
1	PyridinesIBA 12/2019
1	Glucose (Dextrose)FDA LinkGeneric 01/2019
1	CalciumIBA 01/2019
1	Oxygen (Dioxygen)IBA 01/2019
1	Glutamic Acid (Glutamate)FDA Link 01/2019
1	Adenosine A1 ReceptorIBA 01/2019
1	Pharmaceutical PreparationsIBA 07/2018
1	Antineoplastic Agents (Antineoplastics)IBA 07/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 07/2018
1	isofuranodieneIBA 01/2014
1	Bisbenzimidazole (Hoechst 33258)IBA 01/2014
1	Tamsulosin (Flomax)FDA LinkGeneric 12/2010
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 11/2010
1	Rhodopsin (Visual Purple)IBA 03/2010
1	gamma-Aminobutyric Acid (GABA)IBA 09/2009
1	9-ethyladenineIBA 06/2009
1	Adenosine A2 Receptor AntagonistsIBA 06/2009
1	BromineIBA 06/2009
1	Adenosine A2A Receptor (Adenosine A2A Receptors)IBA 12/2008
1	caproctamineIBA 03/2003
1	PolyaminesIBA 03/2003

Therapy/Procedure

9	Therapeutics 01/2022 - 03/2003